Medical robots are an important part of the global medical system, and robotic minimally invasive surgery has become an important representative of the new quality productivity of modern medical care due to its advantages of small trauma, fast recovery and few complications. A few days ago, a remote robotic surgery spanning Chengdu to Lhasa, a distance of more than 2,000 kilometers, was successfully completed, which is the world's first single-arm single-port robotic remote surgery, and is another major breakthrough in the application of cutting-edge minimally invasive technology in China.
The Jingfeng single-arm single-port endoscopic surgical robot used in this operation is a high-end medical equipment completely independently developed in China, and it is also the only single-arm single-port surgical robot approved for marketing in China, which has reached the international leading level in terms of performance parameters. It is reported that Jingfeng Medical, founded in Shenzhen in 2017, independently developed and listed a domestic laparoscopic surgical robot with completely independent intellectual property rights, breaking the technical monopoly of foreign brands, achieving a complete breakthrough in core technology, and also having a new transcendence in key technical parameters; It is the first company in China and the second in the world that both porous and single-port endoscopic surgical robot products have been approved for marketing, and it is also the only company in the world that has completed both remote multi-port and remote single-port robotic human surgery in the remote field.
At the 2024 Shenzhen International High-performance Medical Device Exhibition and Innovative Pharmaceutical Exhibition held recently, Jingfeng Medical brought the latest generation of porous surgical robot MP2000 and single-port surgical robot SP1000 Plus to the show, bringing the world's first multi-porous + single-port + remote "three-in-one" surgical solution, fully demonstrating the technical level and innovative achievements of domestic laparoscopic surgical robots.
In the "2024 Medical Device Industry Innovation Ecology Insight Evaluation" released by the National High-performance Medical Device Innovation Center, Jingfeng Medical ranked among the top 100 cutting-edge enterprises in the medical device industry in 2024, ranking on the list for three consecutive years, and entering the top 10 in the innovation index in the field of surgical robot segmentation; At the same time, its laparoscopic single-port surgical system won the "2024 Innovative Medical Device Product Rising Star", which is the only one among the 10 selected innovative products independently developed by Shenzhen enterprises.
The reporter learned at the scene that the porous surgical robot is the most widely used laparoscopic surgical robot. At present, Jingfeng multi-hole endoscopic surgical robot has carried out more than 5,000 clinical operations in more than 150 hospitals in 27 provinces across the country, and is widely used in various complex minimally invasive surgeries, with a success rate of 100%. Jingfeng single-hole and multi-hole surgical robots can share the doctor's main control platform and imaging platform, the "three-in-one" solution integrates technological innovation, application innovation and model innovation, a set of control system can not only adapt to the porous and single-hole robots at the same time, but also realize the seamless switching of local surgery and remote surgery, so that medical experts can carry out precise surgical operations without visiting the scene, which can effectively alleviate the problem of uneven distribution of medical resources and meet different clinical needs to the greatest extent. It also provides more possibilities for the transformation of medical service models in the future.
In addition, Jingfeng Medical has also signed strategic cooperation agreements with Shenzhen Hospital, Cancer Hospital of Chinese Academy of Medical Sciences, Shenzhen Maternal and Child Health Hospital, Shenzhen Children's Hospital and other hospitals to jointly promote the technological progress of surgical robots and the transformation of scientific research achievements, especially to promote the clinical application and innovative development of single-port surgical robots, and strive to make the fruits of medical technology innovation benefit more patients.